SCHEMBL9439880

SCHEMBL9439880

[CH2]CN1C=COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11513404 0.78
SCHEMBL23198641 0.74
SCHEMBL8675904 0.72
SCHEMBL2188541 0.70
SCHEMBL2492431 0.66 TSHR (0.30)
SCHEMBL18426877 0.66
SCHEMBL6006693 0.64
SCHEMBL28250815 0.64
SCHEMBL1549774 0.57
SCHEMBL7973609 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220041777-A1 RESIN COMPOSITION FOR OPTICAL SHAPING KURARAY NORITAKE DENTAL INC. (JP) 2022-02-10 US disclosed
EP-3900693-A1 RESIN COMPOSITION FOR OPTICAL MOLDING Kuraray Noritake Dental Inc. (JP) 2021-10-27 EP disclosed
CN-106661012-B Carboxamide derivatives 诺华股份有限公司 2019-12-20 CN disclosed
CN-101501030-A Pyrimidine derivatives useful in the treatment of cancer ASTRAZENECA AB (SE) 2009-08-05 CN disclosed
US-5321032-A Peptide compounds and pharmaceutical compositions thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-06-14 US disclosed
EP-0515681-A1 PEPTIDE COMPOUND FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-12-02 EP disclosed